posted on 2016-02-09, 15:47authored byYan Du, Shu Jun Zhen, Bingling Li, Michelle Byrom, Yu Sherry Jiang, Andrew D. Ellington
During the past decade, aptasensors
have largely been designed
on the basis of the notion that ligand-modulated equilibration between
aptamer conformations could be exploited for sensing. One implementation
of this strategy has been to denature the aptamer with an antisense
oligonucleotide, wait for dissociation of the antisense oligonucleotide,
and stabilize the folded, signaling conformer with a ligand. However,
there is a large kinetic barrier associated with releasing the oligonucleotide
from the aptamer to again obtain an active, binding conformation.
If the length of the antisense oligonucleotide is decreased to make
dissociation from the aptamer more favorable, higher background signals
are observed. To improve the general methodology for developing aptasensors,
we have developed a novel and robust strategy for aptasensor design
in which an oligonucleotide kinetically competes with the ligand for
binding rather than having to be released from a stable duplex. While
the oligonucleotide can induce conformational change, it initially
chooses between the aptamer and a molecular beacon (MB), a process
that does not require a lengthy pre-equilibration. Using an anti-ricin
aptamer as a starting point, we developed a “competitive”
aptasensor with a measured limit of detection (LOD) of 30 nM with
an optical readout and as low as 3 nM for ricin toxin A-chain (RTA)
detection on an electrochemical platform.